Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses (Q35899928)

11 August 2017

Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses (English)

1 reference

11 August 2017

personalized medicine

1 reference

12

Razelle Kurzrock

1 reference

Apostolia Maria Tsimberidou

11 August 2017

1

object named as

Apostolia-Maria Tsimberidou

1 reference

11 August 2017

8

Aung Naing

1 reference

11 August 2017

9

Filip Janku

1 reference

11 August 2017

Sijin Wen

2

1 reference

11 August 2017

David S Hong

3

1 reference

11 August 2017

Jennifer J Wheler

4

1 reference

11 August 2017

Gerald S Falchook

5

1 reference

11 August 2017

Siqing Fu

6

1 reference

11 August 2017

Sarina Piha-Paul

7

1 reference

11 August 2017

Kenneth Aldape

10

1 reference

11 August 2017

Yang Ye

11

1 reference

11 August 2017

Donald Berry

13

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 July 2014

1 reference

11 August 2017

Clinical Cancer Research

1 reference

11 August 2017

20

1 reference

11 August 2017

4827-4836

1 reference

11 August 2017

18

1 reference

Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

Comprehensive molecular portraits of human breast tumours

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

Analysis of survival by tumor response.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

The BATTLE trial: personalizing therapy for lung cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

Systematic identification of genomic markers of drug sensitivity in cancer cells

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4518867

Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24987059

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1078-0432.CCR-14-0603

1 reference

11 August 2017

1 reference

11 August 2017

1 reference